share_log

Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Talamo Joseph

SEC announcement ·  Dec 12, 2023 08:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more